CRISPR Therapeutics (CRSP) PT Lowered to $60 at RBC Capital

Go back to CRISPR Therapeutics (CRSP) PT Lowered to $60 at RBC Capital
(NASDAQ: CRSP) Delayed: 53.05 +2.61 (5.17%)
Previous Close $50.44    52 Week High $18.88 
Open $50.82    52 Week Low $13.75 
Day High $53.38    P/E N/A 
Day Low $50.52    EPS $0.00 
Volume 336,312